3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography

  1. Marina Eckermann
  2. Jasper Frohn
  3. Marius Reichardt
  4. Markus Osterhoff
  5. Michael Sprung
  6. Fabian Westermeier
  7. Alexandar Tzankov
  8. Mark Kühnel
  9. Danny Jonigk  Is a corresponding author
  10. Tim Salditt  Is a corresponding author
  1. Georg-August-Universität Göttingen, Germany
  2. Deutsches Elektronen-Synchrotron (DESY), Germany
  3. Universitätsspital Basel, Switzerland
  4. Medizinische Hochschule Hannover (MHH), Germany

Abstract

We present a three-dimensional (3d) approach for virtual histology and histopathology based on multi-scale phase contrast x-ray tomography, and use this to investigate the parenchymal architecture of unstained lung tissue from patients who succumbed to Covid-19. Based on this first proof-of-concept study, we propose multi-scale phase contrast x-ray tomography as a tool to unravel the pathophysiology of Covid-19, extending conventional histology by a third dimension and allowing for full quantification of tissue remodeling. By combining parallel and cone beam geometry, autopsy samples with a maximum cross section of 4mm are scanned and reconstructed at a resolution and image quality which allows for the segmentation of individual cells. Using the zoom capability of the cone beam geometry, regions-of-interest are reconstructed with a minimum voxel size of 167 nm. We exemplify the capability of this approach by 3d visualisation of the DAD with its prominent hyaline membrane formation, by mapping the 3d distribution and density of lymphocytes infiltrating the tissue, and by providing histograms of characteristic distances from tissue interior to the closest air compartment.

Data availability

All datasets were uploaded to zenodo: 10.5281/zenodo.3892637

The following data sets were generated

Article and author information

Author details

  1. Marina Eckermann

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Jasper Frohn

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Marius Reichardt

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Markus Osterhoff

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Michael Sprung

    Petra III, P10, Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Fabian Westermeier

    Petra III, P10, Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Alexandar Tzankov

    Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  8. Mark Kühnel

    Pathology, Medizinische Hochschule Hannover (MHH), Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Danny Jonigk

    Pathology, Medizinische Hochschule Hannover (MHH), Hannover, Germany
    For correspondence
    Jonigk.Danny@mh-hannover.de
    Competing interests
    The authors declare that no competing interests exist.
  10. Tim Salditt

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    For correspondence
    tsaldit@gwdg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4636-0813

Funding

Bundesministerium für Bildung und Forschung (05K19MG2)

  • Tim Salditt

H2020 European Research Council (771883)

  • Danny Jonigk

Max-Planck School (Matter to Life)

  • Marius Reichardt
  • Tim Salditt

Deutsche Forschungsgemeinschaft (-EXC 2067/1-390729940)

  • Tim Salditt

Botnar Research Center of Child Health (BRCCH)

  • Alexandar Tzankov

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The study was approved by and conducted according to requirements of the ethics committees at the Hannover Medical School (vote Nr. 9022 BO K 2020).

Copyright

© 2020, Eckermann et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,554
    views
  • 606
    downloads
  • 41
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marina Eckermann
  2. Jasper Frohn
  3. Marius Reichardt
  4. Markus Osterhoff
  5. Michael Sprung
  6. Fabian Westermeier
  7. Alexandar Tzankov
  8. Mark Kühnel
  9. Danny Jonigk
  10. Tim Salditt
(2020)
3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography
eLife 9:e60408.
https://doi.org/10.7554/eLife.60408

Share this article

https://doi.org/10.7554/eLife.60408

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Hiroyuki Yamamoto, Tetsuro Matano
    Research Article

    HIV and simian immunodeficiency virus (SIV) infections are known for impaired neutralizing antibody (NAb) responses. While sequential virus–host B cell interaction appears to be basally required for NAb induction, driver molecular signatures predisposing to NAb induction still remain largely unknown. Here we describe SIV-specific NAb induction following a virus–host interplay decreasing aberrant viral drive of phosphoinositide 3-kinase (PI3K). Screening of seventy difficult-to-neutralize SIVmac239-infected macaques found nine NAb-inducing animals, with seven selecting for a specific CD8+ T-cell escape mutation in viral nef before NAb induction. This Nef-G63E mutation reduced excess Nef interaction-mediated drive of B-cell maturation-limiting PI3K/mammalian target of rapamycin complex 2 (mTORC2). In vivo imaging cytometry depicted preferential Nef perturbation of cognate Envelope-specific B cells, suggestive of polarized contact-dependent Nef transfer and corroborating cognate B-cell maturation post-mutant selection up to NAb induction. Results collectively exemplify a NAb induction pattern extrinsically reciprocal to human PI3K gain-of-function antibody-dysregulating disease and indicate that harnessing the PI3K/mTORC2 axis may facilitate NAb induction against difficult-to-neutralize viruses including HIV/SIV.

    1. Immunology and Inflammation
    Yan Qian, Qiannv Liu ... Pengyan Xia
    Research Article

    The T6SS of Pseudomonas aeruginosa plays an essential role in the establishment of chronic infections. Inflammasome-mediated inflammatory cytokines are crucial for host defense against bacterial infections. We found that P. aeruginosa infection activates the non-canonical inflammasome in macrophages, yet it inhibits the downstream activation of the NLRP3 inflammasome. The VgrG2b of P. aeruginosa is recognized and cleaved by caspase-11, generating a free C-terminal fragment. The VgrG2b C-terminus can bind to NLRP3, inhibiting the activation of the NLRP3 inflammasome by rejecting NEK7 binding to NLRP3. Administration of a specific peptide that inhibits caspase-11 cleavage of VgrG2b significantly improves mouse survival during infection. Our discovery elucidates a mechanism by which P. aeruginosa inhibits host immune response, providing a new approach for the future clinical treatment of P. aeruginosa infections.